Developments is a biannual newsletter that examines trends of strategic partnering and integrated drug development and provides insights to encourage discussions that result in R&D solutions.  We welcome your feedback and story suggestions.

Developments Newsletter - Spring 2011Spring 2011

TrendS
Drug Discovery Outsourcing: Moving Forward
Growth in Drug Discovery outsourcing penetration may well end up surpassing drug development

Case study
Covance and sanofi-aventis Join in 10-Year Strategic R&D Alliance
Strategic partnering elevated to a whole new level

Insights
Molecule Development Partnerships
Outsourcing all of the work needed to develop a molecule to a single CRO

 

Developments Newsletter - Autumn 2010Autumn 2010

Trends
Three Roads to Positive Returns
Why some pharma companies are following the example of lean biotechs by outsourcing non-core discovery, development, and manufacturing to focus on key areas - speed, cost and quality

Case study
Dedicated Resource Agreement
A mid-sized pharmaceutical company improves R&D efficiency

Insights
Partnering: The Late Stage Advantage
Global CROs offer clients not only flexibility, but also service integration

 

Developments Newsletter - Summer 2009Summer 2009

Trends
Collaborating for Change
Strategic partnerships between sponsors and CROs are proliferating. How will they impact the industry and the future of drug development?

Case Study
The Art of the Asset Transfer
Strategic partnerships vary in structure, but one stands out for its sheer leanness and efficiency

insights
Drug Discovery Outsourcing: Moving Forward
How a strategic outsourcing approach can transform tactical programs for greater R&D success